Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2972086 | The Journal of Heart and Lung Transplantation | 2010 | 6 Pages |
Abstract
Pulmonary hypertension that is secondary to congestive heart failure, as defined by a TPG > 15 mm Hg can be reversed by the use of pulsatile and axial-flow LVADs; furthermore, post-transplant survival for patients with secondary pulmonary hypertension treated with an LVAD was no different than for those without pulmonary hypertension who received LVAD support.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Guillermo MD, PhD, Robert E. MD, Matthias M. MD, PhD, Keith A. PhD, Brian MD, Jerry D. MD, Megan BS, George P. MD,